Bacillus Calmette–Guérin Immunotherapy for Cancer

Bacillus Calmette–Guérin (BCG), an attenuated vaccine from Mycobacterium bovis, was initially developed as an agent for vaccination against tuberculosis. BCG proved to be the first successful immunotherapy against established human bladder cancer and other neoplasms. The use of BCG has been shown to...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardillo, Fabíola, Bonfim, Maiara, da Silva Vasconcelos Sousa, Periela, Mengel, José, Ribeiro Castello-Branco, Luiz Roberto, Pinho, Rosa Teixeira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147207/
https://www.ncbi.nlm.nih.gov/pubmed/34062708
http://dx.doi.org/10.3390/vaccines9050439

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147207/
https://www.ncbi.nlm.nih.gov/pubmed/34062708
http://dx.doi.org/10.3390/vaccines9050439

Ejemplares similares